hARD1 Antiserum Preparation and Primary Immunohistochemical Analysis of hARD1 in Tumor Tissues

Chinese Journal of Biotechnology

Volumn 24, Issue 7, 2008, Pages 1155-1161

  Yu, Min ^a   Huang, Chao ^a   Xiang, Mingjun ^a   Lai, Jianhua ^a   Yang, Hui ^b   Ma, Mingxing ^a   Tan, Deyong ^a  

^a YUNNAN UNIVERSITY   (China)

^b FIRST PEOPLE S HOSPITAL OF YUNNAN PROVINCE   (China)

Author keywords

hARD1 gene; immunohistochemical analysis; tumors

Indexed keywords

ACYLTRANSFERASE; ANTIBODY; ANTISERUM; ARD1A PROTEIN, HUMAN; RECOMBINANT PROTEIN; TUMOR MARKER;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; BREAST TUMOR; ESCHERICHIA COLI; FEMALE; GENETICS; HUMAN; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG TUMOR; MALE; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ACETYLTRANSFERASES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CLONING, MOLECULAR; ESCHERICHIA COLI; FEMALE; HUMANS; IMMUNE SERA; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; TUMOR MARKERS, BIOLOGICAL;

ESCHERICHIA COLI; MUS;

EID: 50949086852     PISSN: 18722075     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1872-2075(08)60057-6     Document Type: Article

References (19)

1. Whiteway M., and Szostak J.W. The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways. Cell 43 (1985) 483-492
2. Park E.C., and Szostal J.W. ARD1 and NAT1 proteins form a complex that has N-terminal acetyl-transferase activity. EMBO J 11 (2000) 2087-2093
3. Mullen J.R., Kayne P.S., Moerschell R.P., et al. Identification and characterization of genes and mutants for an N-terminal acetyltransferase from yeast. EMBO J 8 (1989) 2067-2075
4. Whiteway M., Freedman R., Van Arsdell S., et al. The yeast ARD1 gene product is required for repression of cryptic mating-type information at the HML locus. Mol Cell Biol 7 (1987) 3713-3722
5. Lee F.J., Lin L.W., and Smith J.A. N-acetylation is required for normal growth and mating of Saccharomyces cerevisiae. J Bacteriol 171 (1989) 5795-5802
6. Polevoda B., Norbeck J., Takakura H., et al. Identification and specificities of N-terminal acetyltransferases from Saccharomyces cerevisiae. EMBO J 18 (1999) 6155-6168
7. Naoaki S., Suzanne M.A., and Roderick A.C. An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development. J Biol Chem 278 (2003) 40113-40120
8. Thomas A., Dave A., and Christian B. Identification and characterization of the human ARD1-NATH protein acetyltransferase complex. Biochem J 386 (2005) 433-443
9. He Y.G., Xie Y.F., Chen Y., et al. Cloning and expression of a new human N-acetyl-transferase gene. Acta Biochimica et Biophysica Sinica 34 (2002) 353-357
10. Tribioli C., Mancini M., Plassart E., et al. Isolation of a new gene indistal Xq28: transcriptional map and identification of a human homologue of the ARD1 N-acetyltransferase of Saccharomyces cerevisiae. Hum Mol Genetics 3 (1994) 1061-1067
11. Jeong J.W., Bae M.K., Ahn M.Y., et al. Regulation and destabilization of HIF-1α by ARD1-mediatedAcetylation. Cell 111 (2002) 709-720
12. Bilton R., Mazure N., Trottier E., et al. Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or HIF. J Biol Chem 280 (2005) 31132-31140
13. Fisher T.S., Etages S.D., Hayes L., et al. Analysis of ARD1 function in hypoxia response using retroviral RNA interference. J Biol Chem 280 (2005) 17457-17749
14. Arnesen T., Gromyko D., Pendino F., et al. Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex. Oncogene 25 (2006) 4350-4360
15. Lim J.H., Park J.W., and Chun Y.S. Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation. Cancer Res 66 (2006) 10677-10682
16. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 56 (2006) 106-130
17. Baselga J., Perez E.A., Pienkowski T., et al. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer. Oncogene 11 (2006) 4-12
18. Papaldo P., Fabi A., Ferretti G., et al. A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease. Ann Oncol 17 (2006) 630-636
19. Kouzarides T. Histone acetylases and deactylases in cell proliferation. Curr Opin Genet Dev 9 (1999) 40-48